Activ Surgical Announces Formation of European Advisory Board

Digital surgery pioneer names prominent medical experts to guide pan-European commercialization efforts

BOSTON and ESSEN, Germany, Nov. 10, 2020 /PRNewswire/ -- Activ Surgical [](TM), a digital surgery pioneer, today announced the formation of a European Advisory Board, further investing in its commitment to democratize surgical care and empower global access to best-in-class surgery, regardless of location - saving millions of lives in the process. The European Advisory Board, which consists of world-class surgeons from leading hospital systems across the European Union (EU), will advise Activ Surgical on the company's go-to-market efforts for ActivSight, the company's first product to launch from the ActivEdge [](TM) platform in 2021, as well as offer strategic input on future product plans. The EU Advisory Board will work in collaboration with the company's U.S. Advisory Board [], which was formed in 2019. []

The founding members of Activ Surgical's European Advisory Board include:

-- Prof. Dr. Nicole Bouvy: Dr. Bouvy has spent the last 17 years as a
surgeon and professor at Maastricht University Medical Center's (MUMC+)
Department of Surgery. She specializes in the field of laparoscopic
surgery, head and neck surgery and endocrine surgery, and is viewed as
one of the leading experts for minimally invasive abdomen-based
surgeries. Throughout her career, Dr. Bouvy has been deeply involved in
research that introduces and develops new surgical techniques in order
to improve patient outcomes. She is currently a member of the Executive
Board of the Faculty of Health, Medicine and Life Sciences at MUMC+, and
serves as the Chairman of the Program Committee for the European
Association of Endoscopic Surgery (EAES), of which she has been a member
since 2017.
-- PD Dr. Hans Fuchs: Dr. Fuchs is an assistant Professor of surgery and
Head of Robotic Surgery for the department of surgery at the University
of Cologne, a European High Volume Center for Upper Gastrointestinal
Cancer Surgery. He specializes in upper gastrointestinal surgery, as
well as minimally invasive surgery leveraging the power of robotics.
Much of Dr. Fuchs' scientific and academic research has been focused on
improving outcomes after gastrointestinal surgery using new and
minimally invasive technology. He is currently a member of multiple
scientific societies. He sits on the technology committee of the EAES.
-- Prof. Dr. Kai Nowak: Dr. Nowak is head of surgery at RoMed Klinikum
Rosenheim Hospital in Germany. He is specialized in minimally invasive
surgery with an emphasis on upper gastrointestinal procedures. Dr.
Nowak's research interests include image-guided surgery and pioneering
intraoperative applications of Indocyanine green (ICG) fluorescence. He
is a member of multiple scientific societies with Board Certification in
thoracic surgery, vascular and general surgery.
-- PD Dr. Benjamin Weixler: Dr. Weixler is an attending surgeon at Charité
University Hospital in Berlin, which was named a top five hospital
globally in 2020 by Newsweek. His areas of expertise include liver
cancer, colorectal cancer and minimally invasive surgeries. Dr.
Weixler's areas of interest and research include image-guided surgery in
colorectal and liver cancer surgeries, as he led a clinical trial in
Switzerland in 2014 with a mini-FLARE System for SLN detection in colon
cancer surgery. He is a member of the German Society for General and
Visceral Surgery, the Swiss Association of Residents and Staff
Physicians, the Swiss Society of Surgery and the Swiss Medical
-- Prof. Dr. Luigi Boni: Dr. Boni is the Chief of Surgery at IRCCS - Ca'
Granda - Policlinico Hospital and full professor of surgery at the
University of Milan. He has deep expertise in minimally invasive surgery
techniques having founded the Minimally Invasive Surgery Research Center
in Varese and served as its director for more than a decade. Dr. Boni is
also considered a pioneer in the field of laparoscopic surgery such as
single port, fluorescence guided surgery, mini-laparoscopy and TA-TME.
He serves on the faculty of several renowned research centers across
Europe, including the IRCAD in Strasburg, the Cuschieri Skill Center in
Dundee and the European Surgical Institute in Hamburg, amongst many
Activ Surgical recently announced the opening of its European operations and the appointment of Holger Schipper [] as the general manager and vice president. The European team, along with the newly formed EU Advisory Board, will be tasked with growing visibility and demand for ActivSight and the ActiveEdge platform, which will enable collaborative and, in the future, autonomous surgery through the integration of computer vision, artificial intelligence and robotics. The hardware-agnostic platform enables existing surgical systems, from scopes to robots, to visualize, characterize and track tissue in real-time beyond today's human capability.

"I am thrilled to announce this esteemed group of surgeons as the founding members of our European Advisory Board," said Schipper. "Each of these appointees has extensive, firsthand experience regarding the current and unique challenges surgeons face in the operating room, and they share our vision for improving patient outcomes via breakthrough technology. Their expertise will play a critical role in the commercialization of our ActivEdge platform not only in Europe, but across the globe."

Statement from the Advisory Board: "Activ Surgical's vision and mission for the democratization of surgery is closely aligned with the scientific and academic research we have collectively supported for the majority of our careers. There is a dire need in the operating room to better leverage technologies like artificial intelligence and machine learning to enhance patient safety and reduce surgical errors. We look forward to guiding Activ Surgical as it looks to commercialize its potentially-life saving ActivEdge platform throughout Europe and beyond."

For more information on Activ Surgical, please visit [].

About Activ Surgical
Activ Surgical [], the company that completed the world's first autonomous robotic surgery of soft tissue, is building hardware-agnostic surgical software that allows surgical systems to collaborate with surgeons. Activ Surgical's patent-protected surgical software platform reduces unintended and preventable surgical complications by enhancing a surgeon's intra-operative decision making. Activ Surgical is privately held, and backed by DNS Capital, GreatPoint Ventures (GPV), Artis Ventures, Tao Capital Partners, LRVHealth, Rising Tide VC, SONY Innovation Fund and 8VC. More information can be found at [] [].

Logo - []

CONTACT: Heath Meyer,, 858-768-1527

Web site:

PR Newswire

Dit persbericht is via ANP Pers Support naar internationale (vak en online) media gestuurd. Heb je nieuws voor buitenlandse journalisten? Bekijk dan onze mogelijkheden of neem contact met ons op.

Verstuur nu éénmalig een persbericht

Verstuur persberichten en beeldmateriaal naar redacties in binnen- en buitenland. Via het ANP-net, het internationale medianetwerk van PR Newswire of met een perslijst op maat.

Direct persbericht versturen
070 - 41 41 234